News & Blog

Survey Results: Clinical Trial Participation

  National Brain Tumor Society, in conjunction with neuro-oncologists, scientific researchers, and the biopharmaceutical industry, is constantly looking for new and better treatments for patients. However, scientific progress in a laboratory does not necessarily always lead to new treatments for patients. First, those laboratory results need to be evaluated and confirmed in high quality clinical trials to ensure […]

A Special Message From the CEO

David Arons, JD, was confirmed as the National Brain Tumor Society’s Chief Executive Officer on November 24, 2015. David had been serving in an interim role since mid-summer, and previously as Chief Public Policy & Advocacy Officer since 2011. I came to NBTS in 2011, having already spent nearly two decades in the world of […]

Tsunami: Trial of a brain tumor

Arthur Weinfeld’s vision was in decline. His right eye had become blurry, which made focusing on a sheet of music difficult. At 77, he assumed it was a cataract. With little delay he scheduled an appointment with an ophthalmologist who then agreed that he should have surgery to remove the cataract. After months, however, Arthur’s […]

Share